PATENT CLAIM ANALYSIS

Application Number: 15874506
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-07
Patent Classification: ["424", "499000"]

Abstract:
Disclosed are nanoparticle compositions comprising nanoparticles prepared from denatured, cross-linked albumin and a therapeutic agent for treating a neutrophil-mediated inflammation, and methods of treating neutrophil-mediated inflammation using the compositions.

Claim (Index 1):
A composition comprising nanoparticles, the nanoparticles comprising denatured, cross-linked albumin and an agent selected from a therapeutic agent and a detectable moiety, the nanoparticles being capable of selectively binding to and being internalized by activated neutrophils.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.28
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14316036', '15425528', '14241484', '15129956', '14777304']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7159581912600861
- 35 USC 102 Novelty (BERT): 0.5804982906250364
- Combined Prediction Score: 0.7024122011965812
- Mean Citation Score: 307.4935039999998
- Max Citation Score: 474.35583
- Similarity Product: 447.57414134393343

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test